Loading...
XNAS
ICCM
Market cap57mUSD
Jun 06, Last price  
1.02USD
1D
1.00%
1Q
-24.81%
IPO
-90.69%
Name

Icecure Medical Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
17.45
EPS
—
Div Yield, %
—
Shrs. gr., 5y
29.30%
Rev. gr., 5y
14.70%
Revenues
3m
+1.92%
354,6301,068,586762,873625,487689,3771,071,9021,657,6184,084,5264,138,0003,085,0003,229,0003,291,000
Net income
-15m
L+4.55%
00000000-10,066,000-17,217,000-14,652,000-15,318,000
CFO
-13m
L+0.34%
00000000-12,605,000-14,292,000-12,521,000-12,563,000

Profile

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
URL
https://icecure-medical.com/
IPO date
Feb 02, 2011
Employees
65
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,291
1.92%
3,229
4.67%
3,085
-25.45%
Cost of revenue
18,987
18,805
19,824
Unusual Expense (Income)
NOPBT
(15,696)
(15,576)
(16,739)
NOPBT Margin
Operating Taxes
239
Tax Rate
NOPAT
(15,696)
(15,576)
(16,978)
Net income
(15,318)
4.55%
(14,652)
-14.90%
(17,217)
71.04%
Dividends
Dividend yield
Proceeds from repurchase of equity
9,187
84
13,575
BB yield
Debt
Debt current
298
223
167
Long-term debt
620
975
1,027
Deferred revenue
Other long-term liabilities
Net debt
(6,646)
(9,864)
(22,465)
Cash flow
Cash from operating activities
(12,563)
(12,521)
(14,292)
CAPEX
(71)
(480)
(891)
Cash from investing activities
446
(713)
(891)
Cash from financing activities
9,187
83
13,577
FCF
(15,280)
(14,202)
(18,013)
Balance
Cash
7,564
11,062
23,659
Long term investments
Excess cash
7,399
10,901
23,505
Stockholders' equity
(105,379)
(90,061)
(75,409)
Invested Capital
112,739
102,823
101,428
ROIC
ROCE
EV
Common stock shares outstanding
49,226
45,638
37,017
Price
Market cap
EV
EBITDA
(15,364)
(15,253)
(16,491)
EV/EBITDA
Interest
239
Interest/NOPBT